Do Pharmaceutical Mergers Harm Drug Innovation?

Name: Do Pharmaceutical Mergers Harm Drug Innovation?
Price: 27.95 EUR
Availability: InStock
Author: Jan Schmidt
ISBN: 978-3-656-96217-5

Masterarbeit, 2013

49 Seiten, Note: 8,5 (NL, äquivalent zu 1,2)

Jan Schmidt (Autor:in)

Leseprobe

Tables and Figures

Introduction

1. Theoretical Framework and industry
1.1. Overview of M&A Theory and the pharmaceutical industry
1.2. Review of R&D and the drug approval process

2. Empirical Analyses
2.1. Empirical specification and data
2.1.1. Empirical specification
2.1.2. Data
2.2. Results - Mergers & Acquisitions and R&D intensity
2.3. Mergers & Acquisitions and R&D efficiency

3. Small Acquisitions and their Impact on Industry Efficiency

4. Discussion, Limitations and food for thought

Appendix

Ende der Leseprobe aus 49 Seiten

Details

Titel: Do Pharmaceutical Mergers Harm Drug Innovation?
Hochschule: Universiteit Utrecht (Law, Economics and Governance)
Veranstaltung: Mergers & Akquisitions
Note: 8,5 (NL, äquivalent zu 1,2)
Autor: Jan Schmidt (Autor:in)
Jahr: 2013
Seiten: 49
Katalognummer: V299729
ISBN (eBook): 9783656962168
ISBN (Buch): 9783656962175
Dateigröße: 906 KB
Sprache: Englisch
Schlagworte: pharmaceutical, mergers, harm, drug, innovation

Arbeit zitieren: Jan Schmidt (Autor:in), 2013, Do Pharmaceutical Mergers Harm Drug Innovation?, München, GRIN Verlag, https://www.grin.com/document/299729

Kommentare